LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 64.88 | 771.67 | 3688 | 9447 | 0.3904 | 0.5417 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 67.10 | 771.67 | 3485 | 9800 | 0.3556 | 0.5086 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 67.10 | 771.67 | 3871 | 9800 | 0.3950 | 0.5524 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 69.32 | 771.67 | 3584 | 10212 | 0.3510 | 0.5100 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 69.32 | 771.67 | 3998 | 10212 | 0.3915 | 0.5550 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 71.54 | 771.67 | 3737 | 10532 | 0.3548 | 0.5194 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 71.54 | 771.67 | 4115 | 10532 | 0.3907 | 0.5588 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 73.76 | 771.67 | 3879 | 10851 | 0.3575 | 0.5272 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 73.76 | 771.67 | 4276 | 10851 | 0.3940 | 0.5667 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 76.02 | 771.67 | 4024 | 11106 | 0.3623 | 0.5361 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 76.02 | 771.67 | 4505 | 11106 | 0.4056 | 0.5819 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 78.25 | 771.67 | 4144 | 11367 | 0.3645 | 0.5421 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 78.25 | 771.67 | 4693 | 11367 | 0.4128 | 0.5923 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 80.48 | 771.67 | 4311 | 11685 | 0.3689 | 0.5509 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 80.48 | 771.67 | 4848 | 11685 | 0.4149 | 0.5980 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 82.69 | 771.67 | 4470 | 11974 | 0.3733 | 0.5590 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 82.69 | 771.67 | 5022 | 11974 | 0.4194 | 0.6056 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 84.92 | 771.67 | 4577 | 12266 | 0.3731 | 0.5622 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 84.92 | 771.67 | 5140 | 12266 | 0.4190 | 0.6083 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 87.14 | 771.67 | 4713 | 12592 | 0.3743 | 0.5670 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 87.14 | 771.67 | 5319 | 12592 | 0.4224 | 0.6148 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 2.49 | 771.67 | 803 | 867 | 0.9254 | 0.2650 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 2.49 | 771.67 | 784 | 867 | 0.9035 | 0.0982 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 4.71 | 771.67 | 938 | 956 | 0.9808 | 0.8785 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 4.71 | 771.67 | 889 | 956 | 0.9296 | 0.5796 | MN20160304_L01 | N12 |